Periodontal Disease Therapeutics Market USD 160 Million by 2020, Published by iHealthcareAnalyst, Inc.
Maryland Heights, MO, October 30, 2016 --(PR.com)-- The global periodontal disease therapeutics market is estimated to reach USD 160 Million in 2020, growing at a CAGR of 8.2% from 2016 to 2020, according to a market research report Periodontal Disease Therapeutics Market, 2013-2020, published by iHealthcareAnalyst, Inc.
Visit the Periodontal Disease Therapeutics Market, 2013-2020 report at https://www.ihealthcareanalyst.com/report/periodontal-disease-therapeutics-market/.
The global periodontal disease therapeutics market report provides market size (Revenue USD Million 2013 to 2020), market share, market trends and forecasts growth trends (CAGR%, 2016 to 2020).
Research in recent years in periodontology has seen a shift from surgery towards medicine. Scaling and root planing is sometimes followed by adjunctive therapy such as local delivery antimicrobials, systemic antibiotics, and host modulation, as needed on a case-by-case basis. The antimicrobials have included metronidazole in an ointment form (Elyzol), chlorhexidine (Periochip) as well as doxycycline either in a fiber form (Actisite), or also in a polymeric delivery system (Atridox).
The global periodontal disease therapeutics market segmentation is based on drug types (Arestin, Atridox, Doxycycline, Metronidazole, Minocycline, PerioChip). The global periodontal disease therapeutics market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
1. Drug Type
1.1. Arestin
1.2. Atridox
1.3. Doxycycline
1.4. Metronidazole
1.5. Minocycline
1.6. PerioChip
2. Geography (Region, Country)
2.1. North America (U.S., Canada)
2.2. Latin America (Brazil, Mexico, Rest of LA)
2.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4. Asia Pacific (Japan, China, India, Rest of APAC)
2.5. Middle East
2.6. Rest of the World
3. Company Profiles
3.1. 3M
3.2. DenMat Holdings, LLC
3.3. Dexcel
3.4. Galderma S.A.
3.5. Kaken Pharmaceuticals Co., Ltd
3.6. Valeant Pharmaceuticals
About Us
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.
Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareranalyst.com
Website: https://www.ihealthcareanalyst.com
Visit the Periodontal Disease Therapeutics Market, 2013-2020 report at https://www.ihealthcareanalyst.com/report/periodontal-disease-therapeutics-market/.
The global periodontal disease therapeutics market report provides market size (Revenue USD Million 2013 to 2020), market share, market trends and forecasts growth trends (CAGR%, 2016 to 2020).
Research in recent years in periodontology has seen a shift from surgery towards medicine. Scaling and root planing is sometimes followed by adjunctive therapy such as local delivery antimicrobials, systemic antibiotics, and host modulation, as needed on a case-by-case basis. The antimicrobials have included metronidazole in an ointment form (Elyzol), chlorhexidine (Periochip) as well as doxycycline either in a fiber form (Actisite), or also in a polymeric delivery system (Atridox).
The global periodontal disease therapeutics market segmentation is based on drug types (Arestin, Atridox, Doxycycline, Metronidazole, Minocycline, PerioChip). The global periodontal disease therapeutics market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
1. Drug Type
1.1. Arestin
1.2. Atridox
1.3. Doxycycline
1.4. Metronidazole
1.5. Minocycline
1.6. PerioChip
2. Geography (Region, Country)
2.1. North America (U.S., Canada)
2.2. Latin America (Brazil, Mexico, Rest of LA)
2.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4. Asia Pacific (Japan, China, India, Rest of APAC)
2.5. Middle East
2.6. Rest of the World
3. Company Profiles
3.1. 3M
3.2. DenMat Holdings, LLC
3.3. Dexcel
3.4. Galderma S.A.
3.5. Kaken Pharmaceuticals Co., Ltd
3.6. Valeant Pharmaceuticals
About Us
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.
Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareranalyst.com
Website: https://www.ihealthcareanalyst.com
Contact
iHealthcareAnalyst, Inc.
Ana Aitawa
(314) 736-9294
http://www.ihealthcareanalyst.com/
Ana Aitawa
(314) 736-9294
http://www.ihealthcareanalyst.com/
Contact
Categories